Brera Holdings PLC Class B Ordinary Shares (BREA) had the highest return between June 1, 2022 and May 15, 2023 by a US stock, returning 4,747,900%.
| ASSET | DATE | % RETURN |
|---|---|---|
Brera Holdings PLC Class B Ordinary Shares (BREA) | 6/1/2022 - 5/15/2023 | 4,747,900% |
Polestar Automotive Holding UK PLC Class A ADS (PSNY) | 6/1/2022 - 5/15/2023 | 870,696.46% |
Heart Test Laboratories Inc Common Stock (HSCS) | 6/1/2022 - 5/15/2023 | 279,311.76% |
Next Technology (NXTT) | 6/1/2022 - 5/15/2023 | 44,900% |
SS Innovations International Inc Common Stock (SSII) | 6/1/2022 - 5/15/2023 | 28,828.57% |
Castellum (CTM) | 6/1/2022 - 5/15/2023 | 7,108% |
Foremost Lithium Resource & Technology Ltd Common stock (FMST) | 6/1/2022 - 5/15/2023 | 3,071.43% |
Clean Energy Technologies, Inc Common Stock (CETY) | 6/1/2022 - 5/15/2023 | 2,947.16% |
Viking Therapeutics (VKTX) | 6/1/2022 - 5/15/2023 | 877.33% |
Cabaletta Bio (CABA) | 6/1/2022 - 5/15/2023 | 796.88% |
Ohmyhome Limited Ordinary Shares (OMH) | 6/1/2022 - 5/15/2023 | 712.63% |
TG Therapeutics (TGTX) | 6/1/2022 - 5/15/2023 | 617.74% |
Terns Pharmaceuticals (TERN) | 6/1/2022 - 5/15/2023 | 586.13% |
Ardelyx (ARDX) | 6/1/2022 - 5/15/2023 | 571.18% |
Avadel Pharmaceuticals (AVDL) | 6/1/2022 - 5/15/2023 | 544.89% |
Biomea Fusion (BMEA) | 6/1/2022 - 5/15/2023 | 520.84% |
ENDRA Life Sciences (NDRA) | 6/1/2022 - 5/15/2023 | 457.53% |
Akero Therapeutics (AKRO) | 6/1/2022 - 5/15/2023 | 452.52% |
Rhythm Pharmaceuticals (RYTM) | 6/1/2022 - 5/15/2023 | 385.34% |
United Maritime (USEA) | 6/1/2022 - 5/15/2023 | 377.88% |
Nuvalent (NUVL) | 6/1/2022 - 5/15/2023 | 357.75% |
Reviva Pharmaceuticals (RVPH) | 6/1/2022 - 5/15/2023 | 356.57% |
Synergy CHC Corp Common Stock (SNYR) | 6/1/2022 - 5/15/2023 | 354.2% |
Madrigal Pharmaceuticals (MDGL) | 6/1/2022 - 5/15/2023 | 336.2% |
Immunovant (IMVT) | 6/1/2022 - 5/15/2023 | 335.22% |
